Lexicon Pharmaceuticals reports 2018 executive compensation

CEO Lonnel Coats receives $3.1M

Lexicon Pharmaceuticals reported fiscal year 2018 executive compensation information on March 14, 2019.

In 2018, five executives at Lexicon Pharmaceuticals received on average a compensation package of $1,697,874, a 23% increase compared to previous year.

Average pay of disclosed executives at Lexicon Pharmaceuticals

Lonnel Coats, Chief Executive Officer, received $3,123,433 in total, which increased by 41% compared to 2017. 44.32% of Coats' compensation, or $1,384,268, was in option awards. Coats also received $402,399 in bonus, $634,159 in salary, $690,587 in stock awards, as well as $12,020 in other compensation.

For fiscal year 2018, the median employee pay was $195,778 at Lexicon Pharmaceuticals. Therefore, the ratio of Lonnel Coats' pay to the median employee pay was 16 to one.

Praveen Tyle, Executive Vice President, Research and Development, received a compensation package of $1,464,906, which increased by 13% compared to previous year. 36.98% of the compensation package, or $541,775, was in option awards.

Jeffrey L. Wade, Chief Financial Officer, earned $1,408,003 in 2018, a 16% increase compared to previous year.

Pablo Lapuerta, Chief Medical Officer, received $1,259,810 in 2018, which increases by 17% compared to 2017.

Alexander A. Santini, Executive Vice President and Chief Commercial Officer, earned $1,233,219 in 2018, a 15% increase compared to previous year.